Search

everythinglearnresearchcommunity

for

Search:↓

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Digital gangrene can be an unusual first sign of late-onset lupus.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

Digital gangrene can be an early sign of late-onset systemic lupus erythematosus.

SCAD can indicate ANA-negative lupus, especially in women with unusual symptoms.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The side gland of Suncus murinus is a good model for studying human sebaceous glands.

Serenoa repens extract, alone or with other supplements, improves urinary symptoms and lowers PSA levels.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Protein ubiquitylation is crucial for controlling stem cell functions and could be targeted for cancer treatment.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

Face-lifts can lead to complications like bleeding, nerve injury, skin death, hair loss, and rare infections, with careful surgery reducing risks.

Prednisone may cause multiple skin nodules in lupus patients.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Eating disorders can cause skin problems that need treating the underlying condition for better health.